Tech Company Financing Transactions
Anaborex Funding Round
Anaborex, operating out of La Jolla, scored $3.9 million from Enterprise Partners Venture Capital and TPG Capital.
Transaction Overview
Company Name
Announced On
9/30/2005
Transaction Type
Venture Equity
Amount
$3,900,000
Round
Undisclosed
Investors
Enterprise Partners Venture Capital (Andrew Senyei)
TPG Capital (Fred Cohen)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2223 Avenida de la Playa 300
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Anaborex is an early stage biotechnology company focused on metabolic disease. The company is targeting a variety of metabolic disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Reich
Chief Operating Officer
Richard Kenley
VP - Operations
Jeffrey Rudy
Browse more venture capital transactions:
Prev: 9/30/2005: Airband Communications venture capital transaction
Next: 9/30/2005: INTIO venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs